Corrigendum to “Epidermal growth factor receptors siRNA-conjugated collagen modified gold nanoparticles for targeted imaging and therapy of lung cancer” [Mater. Today Adv. 12 (2021), 100191]
A.Y.-H Yu,
R.-H. Fu,
S.-H. Hsu,
C.-F. Chiu,
W.-H. Fang,
C.-A. Yeh,
C.-M. Tang,
H.-H. Hsieh,
H.-S. Hung
Affiliations
A.Y.-H Yu
Ministry of Health & Welfare, Changhua Hospital, Changhua, Taiwan, ROC
R.-H. Fu
Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC; Translational Medicine Research, China Medical University Hospital, Taichung, Taiwan, ROC
S.-H. Hsu
Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan, ROC
C.-F. Chiu
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC; Division of Chest, Department of Internal Medicine, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan, ROC
W.-H. Fang
Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC
C.-A. Yeh
Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC
C.-M. Tang
College of Oral Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC
H.-H. Hsieh
Blood Bank, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
H.-S. Hung
Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, ROC; Translational Medicine Research, China Medical University Hospital, Taichung, Taiwan, ROC; Corresponding author. Graduate Institute of Biomedical Science, China Medical University, Taichung, 40402, Taiwan, ROC.
